2RT-26594-57573
4 vaccinations
5 coded responses
39 check-ins
5 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 980 / WA
- Registered
- 2020-12-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-17
Registered in v-safe
-
2020-12-17
Dose 1 — Pfizer-BioNTech
- 2020-12-17
-
2020-12-18
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-26
- 2020-12-31
-
2021-01-07
Dose 2 — Pfizer-BioNTech
-
2021-01-07
Survey response — day 0, dose 2MedDRA: Arrhythmia, Atrial fibrillation, Fatigue, Feeling abnormal, Medical observation, Shift work disorder — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessFree text: Difficult to discern fatigue from normal shift work sleep deficit. I also have fairly new onset paroxysmal atrial fibrillation so definitely don't feel great when in that dysrhythmia. (Receiving cardiology care for this)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-16
- 2021-01-21
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-04-08
-
2021-07-08
Survey response — 6 months, dose 2MedDRA: Fatigue, Headache, Nausea — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Headache, nausea, fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-08
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-13
-
2021-10-19
Dose 3 — Pfizer-BioNTech
-
2022-01-09
Survey response — 12 months, dose 2MedDRA: Office visit, Respiratory symptom, SARS-CoV-2 test, SARS-CoV-2 test negative, Sinusitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: I have sinusitis currently. Upper respiratory symptoms non COVID related. Negative COVID-19 PCR · Healthcare visit (other): Employee Health COVID19 testingMedDRA releases: 2024-11 · check-in free text available
-
2022-01-09
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-11
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-04-11
Dose 4 — Pfizer-BioNTech
-
2022-04-11
Survey response — day 0, dose 4MedDRA: Deep vein thrombosis, Unevaluable event — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Systemic reaction (other): Ongoing DVT RLE since Jan 19 2022 - taking xarelto · Healthcare visit (other): On Jan 19, 2022MedDRA releases: 2024-11 · check-in free text available
-
2022-04-11
Report sent to call center — day 0, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2022-04-12
-
2022-04-12
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-04-13
- 2022-04-14
- 2022-04-15
- 2022-04-16
- 2022-04-17
- 2022-04-18
- 2022-04-25
- 2022-05-02
- 2022-05-09
- 2022-05-16
- 2022-05-23
- 2022-07-11
-
2022-10-10
Survey response — 6 months, dose 4MedDRA: COVID-19, Upper respiratory tract infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I currently have an URTI - COVID-19 POSITIVEMedDRA releases: 2024-11 · check-in free text available
-
2022-10-10
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-11
-
2022-10-11
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-04-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech | |
| 3 | 2021-10-19 | Pfizer-BioNTech | No |
| 4 | 2022-04-11 | Pfizer-BioNTech | No |
Call center
4 call center cases
4 successful
Free text
Release 1 — day 0, dose 2
Systemic reaction (other): Difficult to discern fatigue from normal shift work sleep deficit. I also have fairly new onset paroxysmal atrial fibrillation so definitely don't feel great when in that dysrhythmia. (Receiving cardiology care for this)
Release 9 — 6 months, dose 2
Symptoms: Headache, nausea, fatigue
Release 10 — 12 months, dose 2
Symptoms: I have sinusitis currently. Upper respiratory symptoms non COVID related. Negative COVID-19 PCR
Healthcare visit (other): Employee Health COVID19 testing
Release 11 — day 0, dose 4
Systemic reaction (other): Ongoing DVT RLE since Jan 19 2022 - taking xarelto
Healthcare visit (other): On Jan 19, 2022
Release 12 — 6 months, dose 4
Symptoms: I currently have an URTI - COVID-19 POSITIVE
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | SARS-CoV-2 test | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Respiratory symptom | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Arrhythmia | ✓ | ✓ | ✓ |
| SRO | Atrial fibrillation | ✓ | ✓ | ✓ |
| SRO | Deep vein thrombosis | · | · | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Medical observation | ✓ | ✓ | ✓ |
| SRO | Shift work disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release